1.
|
Phase: Phase III Type: Supportive care, Tissue collection/Repository Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000684240, NCCTG-N08C9, N08C9, NCT01198145
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 6 months to 21 years Sponsor: NCI, Other Protocol IDs: CDR0000695661, COG-ACCL0934, ACCL0934, NCT01371656
|
|
3.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: AAA-III-01, 2011-005049-11, NCT01578239
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LX1606.1-301-CS, LX1606.301, NCT01677910
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 1200.167, NCT01814553
|
|
6.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: SAL 2012-0584, NCT01739634
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A7471042, NCT01465802
|
|
8.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 4P-11-3, NCI-2011-03266, NCT01469338
|